ArcelorMittal S.A. (NYSE:MT) shares traded -2.01% lower at $25.87 on Wall Street last session.
In accordance with the data, 14 analysts cover ArcelorMittal S.A. (NYSE:MT). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $40.70 and a low of $27.50, we find $36.32. Given the previous closing price of $26.40, this indicates a potential upside of 37.58 percent. MT stock price is now -4.17% away from the 50-day moving average and -3.81% away from the 200-day moving average. The market capitalization of the company currently stands at $21.89B.
It has been rated a hold by 4 analysts and a buy by 10. Brokers who have rated the stock have averaged $35.94 as their price target over the next twelve months.
A total of 44.80% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in MT stock. A new stake in ArcelorMittal S.A. shares was purchased by ENCOMPASS CAPITAL ADVISORS LLC during the first quarter worth $26,529,000. MARSHALL WACE, LLP invested $10,998,000 in shares of MT during the first quarter. In the first quarter, KGH LTD acquired a new stake in ArcelorMittal S.A. valued at approximately $5,354,000. CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. acquired a new stake in MT for approximately $4,708,000. MILLENNIUM MANAGEMENT LLC purchased a new stake in MT valued at around $4,197,000 in the second quarter. In total, there are 234 active investors with 6.40% ownership of the company’s stock.
ArcelorMittal S.A. (NYSE: MT) opened at $25.94 on Thursday. During the past 12 months, ArcelorMittal S.A. has had a low of $19.25 and a high of $32.49. As of last week, the company has a debt-to-equity ratio of 0.21, a current ratio of 1.60, and a quick ratio of 0.70. The fifty day moving average price for MT is $26.95 and a two-hundred day moving average price translates $26.91 for the stock.
The latest earnings results from ArcelorMittal S.A. (NYSE: MT) was released for Mar, 2023. According to the Steel Company, earnings per share came in at $1.27, beating analysts’ expectations of $0.83 by 0.44. This compares to $4.40 EPS in the same period last year. The net profit margin was 8.20% and return on equity was 11.80% for MT. The company reported revenue of $18.5 billion for the quarter, compared to $21.84 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -15.27 percent.
Moreover, the firm recently paid out its quarterly dividend on 06/15/2023. Investors who held shares on 05/23/2023 were paid a $0.22 dividend. On an annualized basis, this represents a $0.44 dividend and a 1.70% percent yield. There was an ex-dividend date of 05/22/2023 for this dividend. In terms of dividend payout ratio, MT is presently at 5.50%.
ArcelorMittal S.A.(MT) Company Profile
ArcelorMittal S.A., together with its subsidiaries, operates as integrated steel and mining companies in the Americas, Europe, Asia, and Africa. It offers semi-finished flat products, including slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, tinplate, and color coated coils and sheets; semi-finished long products, such as blooms and billets; finished long products consisting of bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company also provides mining products, such as iron ore lumps, fines, concentrates, pellets, and sinter feeds; and coking and pulverized coal injections coal. It sells its products to various customers in the automotive, appliance, engineering, construction, energy, and machinery industries through a centralized marketing organization, as well as distributors. The company has iron ore mining activities in Brazil, Bosnia, Canada, Kazakhstan, Liberia, Mexico, South Africa, and Ukraine; and coal mining activities in Kazakhstan. ArcelorMittal S.A. was founded in 1976 and is headquartered in Luxembourg City, Luxembourg.
